Network analysis identified genes with a degree value >20 as core targets (totaling 43), among which EGFR, AKT1, SRC, MYC, and TNF demonstrated potential close associations with the therapeutic mechanism of WEPT in COPD. This evidence concerns the gene MYC and chronic obstructive pulmonary disease.